Research Preview - The Global Emerging Interventional Cardiac Devices Market
-
Upload
frost-sullivan -
Category
Health & Medicine
-
view
528 -
download
0
Transcript of Research Preview - The Global Emerging Interventional Cardiac Devices Market
India, China and Other Emerging Markets
Key Prospects for Interventional Cardiac
Device Manufactures
Research PREVIEW for the
The Global Emerging Interventional Cardiac
Devices Market
Sample of Key Highlights
• The total revenue generated by sales of emerging interventional cardiac devices
globally in 2013 was estimated to represent a X% increase over the 2012 revenue.
• Revenue in the US market is projected to grow at a compound annual growth rate
(CAGR) of X%, whereas revenue is projected to grow in the European market at X%
and in Rest of World (ROW) at X%, indicating the highest growth.
• The emerging interventional cardiac devices market is currently in its growth phase;
this is attributed to increased levels of awareness of various technologies including
renal denervation (RDN), fractional flow reserve (FFR), and left atrial appendage (LAA)
and the availability of various products in the market.
• With the availability of innovative technologies and strong clinical data evidence, the
interventional cardiac devices market is expected to gain momentum in the
marketplace.
• The US and European markets are the highest-growing regions in the interventional
cardiology space; however, the growth in these regions is likely to be offset by low
procedural volumes and declining average selling prices (ASPs).
Source: Frost & Sullivan analysis.
Sample of Key Highlights
• With the increase in life expectancy and an aging baby-boomer population as well as
the surge in cardiac morbidities, the need for the emerging interventional cardiology
market is bound to increase dramatically by 2020.
• Of Brazil, Russia, India, China (BRIC), South Africa, and South Korea, India and China
contribute the highest growth in terms of CAGR and are a step ahead of regions such
as South Korea and Russia.
• Nonetheless, the BRIC interventional cardiology device market will increase robustly
over the forecast period. Outside of the BRIC nations, other highly targeted countries
include Australia, Turkey, Indonesia, Malaysia, and Mexico.
Source: Frost & Sullivan analysis.
Scope and Segmentation R
es
tra
ints
Restr
ain
ts
Scope
Geographic coverage Global: United States, Europe, and ROW
Study period 2010–2018
Base year 2013
Forecast period 2014–2018
Monetary unit US dollars
Scope and Segmentation
Source: Frost & Sullivan analysis.
• This research service analyses key data and information and provides an in-depth analysis of the
global emerging interventional cardiac devices market.
• The study period covered by this service for the emerging interventional cardiac devices market is from
2010 to 2020, with a CAGR period from 2013 to 2020; the base year is 2013, and the forecast period is
from 2014 to 2020.
• The key geographic areas covered in this study include the United States, Europe, and ROW.
• The 5 key segments covered in this study include transcatheter aortic valve replacement (TAVR), renal
denervation (RDN), bronchial thermoplasty (BT), bioresorbable stents, and FFR. This study does not
include other emerging interventional device market segments.
• This study looks at a series of emerging early-stage interventional technologies; as such, it is approved
as is, and there does not need to be an aggregate total market forecast.
• Revenue for emerging interventional cardiac devices manufacturing companies was obtained from
companies’ annual reports and financial statements.
Executive Summary — CEO’s Perspective
Source: Frost & Sullivan analysis.
2 Significant growth of RDN is expected from various other regions, including Canada, Australia, and Latin America.
3 Favourable demographics will continue to drive the adoption of interventional cardiac devices in growing economies.
4 Technology advances will be witnessed especially in areas of bioresorbable stents and LAA.
5 A significant rise in revenue of coronary stents will be witnessed due to the growing adoption of premium-priced drug-eluting stents.
1 Drug-eluting stents may present regulatory and reimbursement challenges across different
regions.
Executive Summary — 3 Big Predictions
Source: Frost & Sullivan analysis.
2 The price of the devices is increasingly becoming a major factor in competitiveness.
3 An increase in minimally invasive procedures is expected to drive the growth of the market in the next few years.
1 With the increasing use of interventional cardiac procedures, the APAC region is under tremendous pressure to increase the number of trained and skilled medical personnel.
The Full Analysis Features the Following Content
Section Slide Numbers
Executive Summary 9
Market Overview 18
Competitive Playbook 26
Drivers, Restraints, and Trends 32
Forecasts and Trends 41
Market Share and Competitive Analysis 53
Transcatheter Heart Valves Segment Breakdown 55
Renal Denervation Segment Breakdown 68
Bronchial Thermoplasty Segment Breakdown 80
Bioresorbable Stents Segment Breakdown 89
Fractional Flow Reserve Segment Breakdown 99
Country Snapshot—United States 108
Country Snapshot—Europe 111
The Full Analysis Features the Following Content
Section Slide Numbers
The Last Word 117
Appendix 121
Decision Support Database 125
Key Questions the Full Analysis Answers
Source: Frost & Sullivan analysis.
Is the interventional cardiac devices market growing, how long will it continue to grow, and at what rate?
What are the key drivers and trends that lead to growth opportunities?
Which are the most promising segments for manufacturing companies to venture into? Who are the key market participants in each segment?
What market predictions for the forecast period will likely affect manufacturers in the interventional cardiac devices market?
Are the products and services offered today meeting customer needs, or is additional development needed?
What are the trends in use and technology, and is there a shift towards any particular product segment?
List of Exhibits
Source: Frost & Sullivan research.
Exhibit Slide Number
Total Emerging Interventional Cardiac Devices Market: Global, 2013 15
Total Emerging Interventional Cardiac Devices Market: Market Segmentation, Global, 2013 19
Total Emerging Interventional Cardiac Devices Market: Key Market Drivers and Restraints, Global, 2014–2020
33
Total Emerging Interventional Cardiac Devices Market: Market Engineering Measurements, Global, 2013
42
Total Emerging Interventional Cardiac Devices Market: Procurement Process, Global, 2013 51
Total Interventional Cardiac Devices Market: Competitive Structure, Global, 2013 54
Transcatheter Heart Valves Segment: Market Engineering Measurements, Global, 2013 58
Transcatheter Heart Valves Segment: Revenue Forecast, Global, 2010–2020 59
Transcatheter Heart Valves Segment: Market Participants, Global, 2013 64
Transcatheter Heart Valves Segemnt: Comparison of Key TAVR Products, Global, 2013 65
List of Exhibits
Source: Frost & Sullivan research.
Exhibit Slide Number
Transcatheter Heart Valves Segment: Percent of Sales, Global, 2013 66
Transcatheter Heart Valves Segment: Competitive Structure, Global, 2013 67
Renal Denervation Segment: Market Engineering Measurements, Global, 2013 71
Renal Denervation Segment: Revenue Forecast, Global, 2010–2020 72
Renal Denervation Segment: Market Participants, Global, 2013 76
Renal Denervation Segment: Worldwide Market Opportunity, Global, 2013 77
Renal Devervation Segment: Percent of Sales, Global, 2013 78
Renal Denervation Segment: Competitive Structure, Global, 2013 79
Bronchial Thermoplasty Segment: Market Engineering Measurements, Global, 2013 82
Bronchial Thermoplasty Segment: Revenue Forecast, Global, 2010–2020 83
List of Exhibits
Source: Frost & Sullivan research.
Exhibit Slide Number
Bronchial Thermoplasty Segment: Percent of Sales, Global, 2013 87
Bronchial Thermoplasty Segment: Competitive Structure, Global, 2013 88
Bioresorbable Stents Segment: Market Engineering Measurement, Global, 2013 91
Bioresorbable Stents Segment: Revenue Forecast, Global, 2010–2020 92
Bioresorbable Stents Segment: Product Development Status, Global, 2013 96
Bioresorbable Stents Segment: Percent of Sales, Global, 2013 97
Bioresorbable Stents Segment: Competitive Structure, Global, 2013 98
Fractional Flow Reserve Segment: Market Engineering Measurement, Global, 2013 101
Fractional Flow Reserve Segment: Revenue Forecast, Global, 2010–2020 102
Fractional Flow Reserve Segment: Major Market Participants, Global, 2013 105
List of Exhibits
Source: Frost & Sullivan research.
Exhibit Slide Number
Fractional Flow Reserve Segment, Percent of Sales, Global, 2013 106
Fractional Flow Reserve Segment: Competitive Structure, Global, 2013 107
Decision Support Database: Prevalence of Cardiovascular Diseases , Global, 2002–2012
126
Decision Support Database: Population with Hypertension, Global, 2002–2012 127
Decision Support Database: Population Aged Above 65 Years, Global, 2007–2017 128
Associated Multimedia
Analyst Briefings Healthcare & Life Sciences http://bit.ly/1fnYtaN
SlideShare Presentations Healthcare & Life Sciences http://slidesha.re/1hmrb0l
Market Insight Articles Complimentary Healthcare & Life Sciences Analyst Insights http://bit.ly/1hcgeig
GIL Community Frost & Sullivan Community of Growth, Innovation and Leadership http://gil-events.gilcommunity.com/
Analyst Blogs Healthcare & Life Sciences http://bit.ly/1ckACZP
Interested in Full Access? Connect With Us
Jennifer Carson North America Corporate Communications
(210) 247-2450
Research Authors
Swathi Allada Research Analyst
Advanced Medical Technologies
Venkat Rajan Principal Analyst
Advanced Medical Technologies
Siddharth Saha Global Research
Director Advanced Medical
Technologies
Facebook https://www.facebook.com/FrostandSullivan
LinkedIn Group https://www.linkedin.com/company/frost-&-sullivan
SlideShare http://www.slideshare.net/FrostandSullivan
Twitter https://twitter.com/Frost_Sullivan
Industry Convergence Comprehensive Industry Coverage Sparks Innovation Opportunities
Automotive &
Transportation
Aerospace & Defense Measurement &
Instrumentation
Information &
Communication Technologies
Healthcare Environment & Building
Technologies
Energy & Power
Systems
Chemicals, Materials
& Food
Electronics &
Security
Industrial Automation
& Process Control
Automotive
Transportation & Logistics
Consumer
Technologies
Minerals & Mining